Loading...
Humana AB (publ)
0RF7.L•LSE
HealthcareMedical - Care Facilities
£48.00
£0.00(0.00%)
Humana AB (publ) (0RF7.L) Financial Performance & Statements
Review Humana AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.69%
↑ 6.69%
Operating Income Growth
23.54%
↑ 23.54%
Net Income Growth
-18.18%
↓ 18.18%
Operating Cash Flow Growth
39.94%
↑ 39.94%
Operating Margin
3.86%
↑ 3.86%
Gross Margin
21.94%
↑ 21.94%
Net Profit Margin
0.60%
↑ 0.60%
ROE
1.00%
↑ 1.00%
ROIC
2.31%
↑ 2.31%
Humana AB (publ) (0RF7.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Humana AB (publ) stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.69B | $2.67B | $2.54B | $2.41B |
| Cost of Revenue | $0.00 | $2.46B | $2.41B | $2.30B |
| Gross Profit | $2.69B | $203.00M | $129.00M | $111.00M |
| Gross Profit Ratio | $1.00 | $0.08 | $0.05 | $0.05 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $2.47B | $307.00M | $283.00M |
| Operating Expenses | $2.58B | $2.47B | $2.46B | $2.32B |
| Total Costs & Expenses | $2.58B | $2.47B | $2.41B | $2.30B |
| Interest Income | $2.00M | $2.00M | $5.00M | $5.00M |
| Interest Expense | $67.00M | $76.00M | $77.00M | $66.00M |
| Depreciation & Amortization | $147.00M | $153.00M | $143.00M | $139.00M |
| EBITDA | $255.00M | $350.00M | $228.00M | $231.00M |
| EBITDA Ratio | $0.09 | $0.13 | $0.09 | $0.10 |
| Operating Income | $106.00M | $195.00M | $129.00M | $111.00M |
| Operating Income Ratio | $0.04 | $0.07 | $0.05 | $0.05 |
| Other Income/Expenses (Net) | -$65.00M | -$74.00M | -$72.00M | -$61.00M |
| Income Before Tax | $41.00M | $121.00M | $8.00M | $26.00M |
| Income Before Tax Ratio | $0.02 | $0.05 | $0.003 | $0.01 |
| Income Tax Expense | $11.00M | $27.00M | $7.00M | $5.00M |
| Net Income | $28.00M | $94.00M | $1.00M | $21.00M |
| Net Income Ratio | $0.01 | $0.04 | $0.00 | $0.009 |
| EPS | $0.54 | $1.81 | $0.02 | $0.44 |
| Diluted EPS | $0.54 | $1.81 | $0.02 | $0.44 |
| Weighted Avg Shares Outstanding | $51.83M | $51.83M | $49.15M | $47.83M |
| Weighted Avg Shares Outstanding (Diluted) | $51.83M | $51.83M | $49.15M | $47.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan